| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.21 | 7e-07 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0001 |